GLP-1 diabetes drugs linked to up to 68% higher hair loss risk

The usage of glucagon-like peptide-1 (GLP-1) receptor agonists to dainty benignant 2 diabetes and obesity is associated with an accrued hazard of hairsbreadth nonaccomplishment (alopecia) successful adults with benignant 2 diabetes, a survey published by The BMJ finds. Although the implicit hazard is low, consciousness of this imaginable effect whitethorn assistance pass shared attraction decisions, the researchers say.